LAKE FOREST, Ill., July 29 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP - News), a leading global specialty pharmaceutical and medication delivery company, today reported results for the second quarter ended June 30, 2009. Net sales for the quarter were $957 million, and adjusted* diluted earnings per share were $0.73. (Adjusted* measures exclude certain specified items as described later in this press release and the attached schedules.)
